Updates

October 17, 2019October 17, 2019
People With Bipolar Disorder Face Higher Risk of Later Developing Parkinson’s, Study Finds

People with bipolar disorder have a significantly increased risk — more than three times that of the general population — of later developing Parkinson’s ... Read more
October 17, 2019October 17, 2019
Nourianz Now Available in US as Add-on to Carbidopa/Levodopa to Treat Parkinson’s Off Periods

Kyowa Kirin’s Nourianz (istradefylline) tablets are now available in the United States as an add-on treatment for off periods in Parkinson’s disease patients on a ... Read more
October 16, 2019October 16, 2019
Polypharmacy Linked to Cognitive Decline in Newly Diagnosed Parkinson’s Patients, Study Finds

Taking several different medications at the same time to treat concurrent health conditions — known as polypharmacy — may be associated with cognitive decline ... Read more
October 16, 2019October 14, 2019
‘Get It On Time’ Petition Seeks Better Access to Parkinson’s Meds in UK

A healthcare petition called “Get It On Time” is circulating in the U.K. among people with Parkinson’s disease (PD). According to the petition, hospitalized ... Read more
October 16, 2019October 16, 2019
Veterans with PTSD or Brain Injury at Risk of Sleep Disorder That Might Signal Parkinson’s, Study Finds

Military veterans with post-traumatic stress disorder (PTSD) or who experienced a traumatic brain injury have more than double the risk of a rare sleep ... Read more

Average Rating

0 out of 5 stars. 0 votes.

News

Mutations in Alpha-Synuclein Speed Protein Clumping in Familial Parkinson’s and Affect Severity, Study Finds
October 15, 2019October 15, 2019
A detailed analysis of alpha-synuclein — a key protein involved in Parkinson’s — revealed ...
News

Safety and Efficacy of Oral Cannabidiol in Treating Parkinson’s Psychosis Focus of Phase 2 Study in UK
October 15, 2019October 15, 2019
A planned Phase 2 clinical trial will assess the safety and effectiveness of pharmaceutical-grade ...
Columns, Journeying Through Parkinson's Disease   - a column by Sherri Woodbridge

We Share a Fear of Being a Burden, but We All Need Someone
October 14, 2019October 10, 2019
“You’re not a burden. You’re a human.” –Anonymous It’s easy to feel alone when ...
News

Researchers Using Real-time Brain Mapping to Search for Therapeutic Targets in PD
October 14, 2019October 14, 2019
Using its brain mapping platform, Inscopix will team up with researchers at the Broad ...
News

$20M Grant Awarded for Research into Imaging Protein Misfolding in Parkinson’s
October 14, 2019October 14, 2019
The National Institute of Neurological Disorders and Stroke (NINDS) has awarded a five-year, $20 ...
Columns, Dr. C's Journey with PD - a column by Dr. C

Letting Go Is Not ‘Forever Gone’
October 11, 2019October 9, 2019
“Letting go” is a constant theme with Parkinson’s disease. What used to be easy ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Average Rating

0 out of 5 stars. 0 votes.

Genetic Parkinson’s More Common Than Thought, Global Survey Reveals
October 11, 2019October 11, 2019
Cases of inherited Parkinson’s disease may be more frequent than previously reported, results from ...
FIRE-UP PD Initiative Seeks to Increase Inclusivity in Parkinson’s Research
October 11, 2019October 11, 2019
The Michael J. Fox Foundation (MJFF) and Massachusetts General Hospital have announced an initiative to ...
Potential Treatment to Prevent Toxic Protein Clumping Enters Phase 1 Trial, Yumanity Announces
October 10, 2019October 10, 2019
MIT Scientists Building Artificial Gut to Study Bacteria’s Influence on Parkinson’s, Other Diseases
October 10, 2019October 10, 2019
True Grit Is What It Takes
October 9, 2019October 7, 2019
High Intensity Interval Training May Benefit Patients with Parkinson’s, Pilot Study Shows
October 9, 2019October 9, 2019

Average Rating

0 out of 5 stars. 0 votes.

Middle-aged People Have Up to 20-Year Window to Reduce PD Risk, Oxford Health Policy Report Says
October 9, 2019October 9, 2019
In calling for a public health campaign to promote a brain-healthy lifestyle, an Oxford ...
Review Highlights Sex-related Differences In Parkinson’s
October 8, 2019October 8, 2019
Impaired Immune Cells May Contribute to Parkinson’s Progression, Study Suggests
October 8, 2019October 8, 2019
With Parkinson’s, the Good Is Worth the Fight
October 7, 2019October 3, 2019

Average Rating

0 out of 5 stars. 0 votes.

Nuplazid ‘Significantly’ Slows Relapses in Dementia-Related Psychosis, Phase 3 Trial Shows
October 7, 2019October 7, 2019
Interim results from the ongoing Phase 3 HARMONY study show that treatment with Nuplazid ...
Patients’ Self-reported Symptoms Reflect Clinical Assessments of Parkinson’s Severity, Study Finds
October 7, 2019October 7, 2019
A Scientific Model of Sanctuary Helps Me to Overcome Resistance
October 4, 2019October 2, 2019

Average Rating

0 out of 5 stars. 0 votes.

News

Wearable Sensors Offer Way of Ably Monitoring Day-to-Day Movement in Parkinson’s Patients, Study Says
October 4, 2019October 4, 2019
Electronically monitoring Parkinson’s symptoms as people go about their day is a feasible way ...
News

Interaction of Gene Variants Dictates Parkinson’s Risk, Study Finds
October 4, 2019October 4, 2019
Scientists have discovered that the individual contribution of gene variants known to increase the ...
Columns, Life, Lemons, and Lemonade – a Column by Lori DePorter

Empower Yourself by Making Good Choices
October 3, 2019September 30, 2019
Medication is more than the regimen of pills we take every day. Exercise, diet, ...
News

Phase 2 Trial of SEP-363856, Potential Oral Treatment of Parkinson’s Psychosis, Enrolling in US
October 3, 2019October 3, 2019
A Phase 2 clinical trial of SEP-363856, an oral treatment candidate for people with Parkinson’s psychosis, ...
News

Silverstein Foundation, Q-State Launch Company Aiming to Treat Parkinson’s Linked to GBA Mutations
October 3, 2019October 3, 2019
The Silverstein Foundation for Parkinson’s with GBA together with Q-State Biosciences have launched Chamishi Therapeutics, ...
Columns, Shaking Things Up - a Column by Mary Beth Skylis

James Parkinson’s Work Paved the Way for Future Research
October 2, 2019October 2, 2019
James Parkinson changed the course of medical history when he first described the “Shaking ...
Columns, Journeying Through Parkinson's Disease   - a column by Sherri Woodbridge

Are You a Victim or a Winner?
October 2, 2019September 30, 2019
When I think of a victim, I think of someone who has had something ...
News

Scientists Identify Potential Biomarker That Could Open New Avenues for Parkinson’s Treatment
October 2, 2019October 2, 2019
Researchers have found a compound that can rescue dopaminergic neurons from cell death and ...
News

LRRK2 Gene Mutation Protects Against Infection But Increases Parkinson’s Risk Via Inflammation, Study Suggests
October 2, 2019October 2, 2019
Although it may be protective against infections, a specific mutation in the LRRK2 gene ...
Columns, Slow is the New Fast - a Column by Jean Mellano

Parkinson’s Is My New Mountain
October 1, 2019September 27, 2019
In the spring of 2006, I was with a cycling group that headed out ...
News

Neuroscientist Awarded $2.9M NIH Grant to Study and Possibly Prevent Side Effects of Levodopa
October 1, 2019October 1, 2019
The National Institutes of Health has awarded a $2.9 million grant to a Feinstein Institutes ...
News

Nuplazid Eases Depression in Parkinson’s Patients, Phase 2 Trial Shows
October 1, 2019October 1, 2019
Treatment with Nuplazid (pimavanserin), approved in the U.S. for treating hallucinations and delusions associated ...
Columns, Journeying Through Parkinson's Disease   - a column by Sherri Woodbridge

Playing Helps to Calm a Blustery Day with Parkinson’s
September 30, 2019September 26, 2019
Fall is rapidly passing by, and with it goes your last opportunity to fly ...
News

Daily Use of Cala Trio Device Effectively Eases Hand Tremors, Trial Reports
September 30, 2019September 30, 2019
Using Cala Health’s non-invasive therapeutic device Cala Trio for 40 minutes twice daily effectively ...
News

Tavapadon Lessens Motor Symptoms in Patients with Early-stage Parkinson’s, Phase 2 Trial Finds
September 30, 2019September 30, 2019
Oral treatment with tavapadon eased motor symptoms and was well-tolerated by patients with early-stage ...

June 22, 2018June 22, 2018

New Tool Effectively Monitors Sleep Quality in Parkinson’s Patients, Researchers Say

News

A new tool called cardiopulmonary coupling could be used to effectively evaluate sleep quality in Parkinson’s disease patients, who often experience sleep disorders, according to a study. The study, “Assessment of sleep quality using cardiopulmonary coupling analysis in patients with ... Read more

Subscribe to our mailing list

Pin It on Pinterest